Enanta Pharmaceuticals, Inc. To Present At The JMP Securities Life Sciences Conference

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present a corporate overview followed by a question and answer session with investors on June 23, 2015 at 10:30 a.m. ET during the JMP Securities Life Sciences Conference.

Help employers find you! Check out all the jobs and post your resume.

Back to news